Véronique BRAUD – IPMC

Recherche

Intranet

Thème

Aurore DUMOND BOURIE

Présentation

Page à Venir….

Événements

Véronique BRAUD invite le Dr. Cyril FAURIAT

“Bone marrow microenvironment remodeling during leukemia initiation”

Projets

Développement d’anticorps thérapeutiques et de diagnostic dirigés contre la molécule LLT1

Suite à nos travaux ayant identifié l’interaction entre LLT1 (Lectin-Like Transcript 1) et son récepteur CD161 (NKRP-1A) exprimé en surface […]

Impact de stress environnementaux sur l’intégrité de la peau

Nous travaillons en étroite collaboration avec PKDerm, une société spécialisée dans le développement et la commercialisation de tests d’efficacité et […]

Caractérisation et régulation des cellules immunitaires innées au sein du microenvironnement des cancers épithéliaux

La peau et les muqueuses de la cavité buccale sont des tissus épithéliaux immunocompétents en contact direct avec l’environnement. Ils […]

Publications

Olal C, Bodmer BS, Rottstegge M, Escudero-Pérez B, Port JR, Bencsik A, Nelson EV, Heung M, Wurr S, Blake O, Adam E, Oestereich L, Baz-Martínez M, Müller-Guhl J, Gallais Y, Anjuère F, Malliere B, Idoyaga J, Hoenen T, Muñoz-Fontela C, Antibody-Based Antigen Delivery to Dendritic Cells as a Vaccination Strategy Against Ebola Virus Disease., J Infect Dis 2025 Apr; 231(4): e615-e625.

Iltis C, Moskalevska I, Debiesse A, Seguin L, Fissoun C, Cervera L, Moudombi L, Ardin M, Ferrari A, Eliott C, Pisani D, Ottaviani A, Bourinet M, Luci C, Gual P, Makulyte G, Bernard D, Durandy M, Duret LC, Hamidouche T, Kunz S, Croce O, Delannoy C, Guérardel Y, Allain F, Hofman P, Benarroch-Popivker D, Bianchini L, Dadone-Montaudie B, Cosson E, Guglielmi J, Pourcher T, Braud VM, Shkreli M, Pers YM, Jorgensen C, Brondello JM, Féral CC, Michallet MC, Gilson E, Cherfils-Vicini J, A ganglioside-based immune checkpoint enables senescent cells to evade immunosurveillance during aging., Nat Aging 2025 Feb; 5(2): 219-236.

Fotso CT, Girel S, Anjuère F, Braud VM, Hubert F, Goudon T, A mixture-like model for tumor-immune system interactions., J Theor Biol 2024 Mar; 581(): 111738.

Barthe M, Clerbaux LA, Thénot JP, Braud VM, Osman-Ponchet H, Systematic characterization of the barrier function of diverse ex vivo models of damaged human skin., Front Med (Lausanne) 2024 ; 11(): 1481645.

Elaldi R, Chamorey E, Schiappa R, Sudaka A, Anjuère F, Villarmé A, Culié D, Bozec A, Montaudié H, Poissonnet G, Comparative Performance of Four Staging Classifications to Select «High-Risk» Head and Neck Cutaneous Squamous Cell Carcinomas., J Clin Med 2023 Jun; 12(12): .

Barthe M, Hertereau L, Lamghari N, Osman-Ponchet H, Braud VM, Receptors and Cofactors That Contribute to SARS-CoV-2 Entry: Can Skin Be an Alternative Route of Entry?, Int J Mol Sci 2023 Mar; 24(7): .

Bourdely P, Petti L, Khou S, Meghraoui-Kheddar A, Elaldi R, Cazareth J, Mossadegh-Keller N, Boyer J, Sieweke MH, Poissonnet G, Sudaka A, Braud VM, Anjuère F, Autofluorescence identifies highly phagocytic tissue-resident macrophages in mouse and human skin and cutaneous squamous cell carcinoma., Front Immunol 2022 ; 13(): 903069.

Atsou K, Khou S, Anjuère F, Braud VM, Goudon T, Analysis of the Equilibrium Phase in Immune-Controlled Tumors Provides Hints for Designing Better Strategies for Cancer Treatment., Front Oncol 2022 ; 12(): 878827.

Braud VM, Meghraoui-Kheddar A, Elaldi R, Petti L, Germain C, Anjuère F, LLT1-CD161 Interaction in Cancer: Promises and Challenges., Front Immunol 2022 ; 13(): 847576.

Duurland CL, Santegoets SJ, Abdulrahman Z, Loof NM, Sturm G, Wesselink TH, Arens R, Boekestijn S, Ehsan I, van Poelgeest MIE, Finotello F, Hackl H, Trajanoski Z, Ten Dijke P, Braud VM, Welters MJP, van der Burg SH, CD161 expression and regulation defines rapidly responding effector CD4+ T cells associated with improved survival in HPV16-associated tumors., J Immunother Cancer 2022 Jan; 10(1): .

Luci C, Bihl F, Bourdely P, Khou S, Popa A, Meghraoui-Kheddar A, Vermeulen O, Elaldi R, Poissonnet G, Sudaka A, Bozec A, Bekri S, Cazareth J, Ponzio G, Barbry P, Rezzonico R, Mari B, Braud VM, Anjuère F, Cutaneous Squamous Cell Carcinoma Development Is Associated with a Temporal Infiltration of ILC1 and NK Cells with Immune Dysfunctions., J Invest Dermatol 2021 Oct; 141(10): 2369-2379.

Elaldi R, Hemon P, Petti L, Cosson E, Desrues B, Sudaka A, Poissonnet G, Van Obberghen-Schilling E, Pers JO, Braud VM, Anjuère F, Meghraoui-Kheddar A, High Dimensional Imaging Mass Cytometry Panel to Visualize the Tumor Immune Microenvironment Contexture., Front Immunol 2021 ; 12(): 666233.

Atsou K, Anjuère F, Braud VM, Goudon T, A size and space structured model of tumor growth describes a key role for protumor immune cells in breaking equilibrium states in tumorigenesis., PLoS One 2021 ; 16(11): e0259291.

Atsou K, Anjuère F, Braud VM, Goudon T, A size and space structured model describing interactions of tumor cells with immune cells reveals cancer persistent equilibrium states in tumorigenesis., J Theor Biol 2020 Apr; 490(): 110163.

Gonçalves-Maia M, Gache Y, Basante M, Cosson E, Salavagione E, Muller M, Bernerd F, Avril MF, Schaub S, Sarasin A, Braud VM, Magnaldo T, NK Cell and Fibroblast-Mediated Regulation of Skin Squamous Cell Carcinoma Invasion by CLEC2A Is Compromised in Xeroderma Pigmentosum., J Invest Dermatol 2020 Sep; 140(9): 1723-1732.

Khou S, Popa A, Luci C, Bihl F, Meghraoui-Kheddar A, Bourdely P, Salavagione E, Cosson E, Rubod A, Cazareth J, Barbry P, Mari B, Rezzonico R, Anjuère F, Braud VM, Tumor-Associated Neutrophils Dampen Adaptive Immunity and Promote Cutaneous Squamous Cell Carcinoma Development., Cancers (Basel) 2020 Jul; 12(7): .

Braud VM, Biton J, Becht E, Knockaert S, Mansuet-Lupo A, Cosson E, Damotte D, Alifano M, Validire P, Anjuère F, Cremer I, Girard N, Gossot D, Seguin-Givelet A, Dieu-Nosjean MC, Germain C, Expression of LLT1 and its receptor CD161 in lung cancer is associated with better clinical outcome., Oncoimmunology 2018 ; 7(5): e1423184.

Bekri S, Bourdely P, Luci C, Dereuddre-Bosquet N, Su B, Martinon F, Braud VM, Luque I, Mateo PL, Crespillo S, Conejero-Lara F, Moog C, Le Grand R, Anjuère F, Sublingual Priming with a HIV gp41-Based Subunit Vaccine Elicits Mucosal Antibodies and Persistent B Memory Responses in Non-Human Primates., Front Immunol 2017 ; 8(): 63.

Fassy J, Tsalkitzi K, Goncalves-Maia M, Braud VM, A Real-Time Cytotoxicity Assay as an Alternative to the Standard Chromium-51 Release Assay for Measurement of Human NK and T Cell Cytotoxic Activity., Curr Protoc Immunol 2017 Aug; 118(): 7.42.1-7.42.12.

Fassy J, Tsalkitzi K, Salavagione E, Hamouda-Tekaya N, Braud VM, A real-time digital bio-imaging system to quantify cellular cytotoxicity as an alternative to the standard chromium-51 release assay., Immunology 2017 Apr; 150(4): 489-494.

Germain C, Guillaudeux T, Galsgaard ED, Hervouet C, Tekaya N, Gallouet AS, Fassy J, Bihl F, Poupon G, Lazzari A, Spee P, Anjuère F, Pangault C, Tarte K, Tas P, Xerri L, Braud VM, Lectin-like transcript 1 is a marker of germinal center-derived B-cell non-Hodgkin’s lymphomas dampening natural killer cell functions., Oncoimmunology 2015 Aug; 4(8): e1026503.

Luci C, Bekri S, Bihl F, Pini J, Bourdely P, Nouhen K, Malgogne A, Walzer T, Braud VM, Anjuère F, NKp46+ Innate Lymphoid Cells Dampen Vaginal CD8 T Cell Responses following Local Immunization with a Cholera Toxin-Based Vaccine., PLoS One 2015 ; 10(12): e0143224.

Hervouet C, Luci C, Bekri S, Juhel T, Bihl F, Braud VM, Czerkinsky C, Anjuère F, Antigen-bearing dendritic cells from the sublingual mucosa recirculate to distant systemic lymphoid organs to prime mucosal CD8 T cells., Mucosal Immunol 2014 Mar; 7(2): 280-91.

Chatelain FC, Bichet D, Feliciangeli S, Larroque MM, Braud VM, Douguet D, Lesage F, Silencing of the tandem pore domain halothane-inhibited K+ channel 2 (THIK2) relies on combined intracellular retention and low intrinsic activity at the plasma membrane., J Biol Chem 2013 Dec; 288(49): 35081-92.

Anjuère F, Bekri S, Bihl F, Braud VM, Cuburu N, Czerkinsky C, Hervouet C, Luci C, B cell and T cell immunity in the female genital tract: potential of distinct mucosal routes of vaccination and role of tissue-associated dendritic cells and natural killer cells., Clin Microbiol Infect 2012 Oct; 18 Suppl 5(): 117-22.

Prod'homme V, Tomasec P, Cunningham C, Lemberg MK, Stanton RJ, McSharry BP, Wang EC, Cuff S, Martoglio B, Davison AJ, Braud VM, Wilkinson GW, Human cytomegalovirus UL40 signal peptide regulates cell surface expression of the NK cell ligands HLA-E and gpUL18., J Immunol 2012 Mar; 188(6): 2794-804.

Germain C, Meier A, Jensen T, Knapnougel P, Poupon G, Lazzari A, Neisig A, Håkansson K, Dong T, Wagtmann N, Galsgaard ED, Spee P, Braud VM, Induction of lectin-like transcript 1 (LLT1) protein cell surface expression by pathogens and interferon-γ contributes to modulate immune responses., J Biol Chem 2011 Nov; 286(44): 37964-37975.

Bihl F, Germain C, Luci C, Braud VM, Mechanisms of NK cell activation: CD4(+) T cells enter the scene., Cell Mol Life Sci 2011 Nov; 68(21): 3457-67.

Luci C, Anjuère F, IFN-λs and BDCA3+/CD8α+ dendritic cells: towards the design of novel vaccine adjuvants?, Expert Rev Vaccines 2011 Feb; 10(2): 159-61.

Guilmot A, Hermann E, Braud VM, Carlier Y, Truyens C, Natural killer cell responses to infections in early life., J Innate Immun 2011 ; 3(3): 280-8.

Czerkinsky C, Cuburu N, Kweon MN, Anjuere F, Holmgren J, Sublingual vaccination., Hum Vaccin 2011 Jan; 7(1): 110-4.

Germain C, Bihl F, Zahn S, Poupon G, Dumaurier MJ, Rampanarivo HH, Padkjær SB, Spee P, Braud VM, Characterization of alternatively spliced transcript variants of CLEC2D gene., J Biol Chem 2010 Nov; 285(46): 36207-15.

Bihl F, Pecheur J, Bréart B, Poupon G, Cazareth J, Julia V, Glaichenhaus N, Braud VM, Primed antigen-specific CD4+ T cells are required for NK cell activation in vivo upon Leishmania major infection., J Immunol 2010 Aug; 185(4): 2174-81.

Hervouet C, Luci C, Cuburu N, Cremel M, Bekri S, Vimeux L, Marañon C, Czerkinsky C, Hosmalin A, Anjuère F, Sublingual immunization with an HIV subunit vaccine induces antibodies and cytotoxic T cells in the mouse female genital tract., Vaccine 2010 Aug; 28(34): 5582-90.

Hervouet C, Luci C, Rol N, Rousseau D, Kissenpfennig A, Malissen B, Czerkinsky C, Anjuère F, Langerhans cells prime IL-17-producing T cells and dampen genital cytotoxic responses following mucosal immunization., J Immunol 2010 May; 184(9): 4842-51.

Hermann E, Berthe A, Truyens C, Alonso-Vega C, Parrado R, Torrico F, Carlier Y, Braud VM, Killer cell immunoglobulin-like receptor expression induction on neonatal CD8(+) T cells in vitro and following congenital infection with Trypanosoma cruzi., Immunology 2010 Mar; 129(3): 418-26.

Cuburu N, Kweon MN, Hervouet C, Cha HR, Pang YY, Holmgren J, Stadler K, Schiller JT, Anjuère F, Czerkinsky C, Sublingual immunization with nonreplicating antigens induces antibody-forming cells and cytotoxic T cells in the female genital tract mucosa and protects against genital papillomavirus infection., J Immunol 2009 Dec; 183(12): 7851-9.

Bertin S, Anjuere F, Gavelli A, Baque P, Soilihi BK, Brossette N, Loubat A, Pierrefite-Carle V, Plasmidic CpG sequences induce tumor microenvironment modifications in a rat liver metastasis model., Int J Mol Med 2008 Mar; 21(3): 309-15.

Cuburu N, Kweon MN, Song JH, Hervouet C, Luci C, Sun JB, Hofman P, Holmgren J, Anjuère F, Czerkinsky C, Sublingual immunization induces broad-based systemic and mucosal immune responses in mice., Vaccine 2007 Dec; 25(51): 8598-610.

Anjuère F, Czerkinsky C, [Mucosal immunity and vaccine development]., Med Sci (Paris) 2007 Apr; 23(4): 371-8.

Bajénoff M, Breart B, Huang AY, Qi H, Cazareth J, Braud VM, Germain RN, Glaichenhaus N, Natural killer cell behavior in lymph nodes revealed by static and real-time imaging., J Exp Med 2006 Mar; 203(3): 619-31.

Anjuère F, Luci C, Hervouet C, Rousseau D, Czerkinsky C, Transepithelial immunomodulation by cholera toxin and non-toxic derivatives., Vaccine 2006 Apr; 24 Suppl 2(): S2-62.

Luci C, Hervouet C, Rousseau D, Holmgren J, Czerkinsky C, Anjuère F, Dendritic cell-mediated induction of mucosal cytotoxic responses following intravaginal immunization with the nontoxic B subunit of cholera toxin., J Immunol 2006 Mar; 176(5): 2749-57.

Aldemir H, Prod'homme V, Dumaurier MJ, Retiere C, Poupon G, Cazareth J, Bihl F, Braud VM, Cutting edge: lectin-like transcript 1 is a ligand for the CD161 receptor., J Immunol 2005 Dec; 175(12): 7791-5.

Anjuère F, Luci C, Lebens M, Rousseau D, Hervouet C, Milon G, Holmgren J, Ardavin C, Czerkinsky C, In vivo adjuvant-induced mobilization and maturation of gut dendritic cells after oral administration of cholera toxin., J Immunol 2004 Oct; 173(8): 5103-11.

Hansasuta P, Dong T, Thananchai H, Weekes M, Willberg C, Aldemir H, Rowland-Jones S, Braud VM, Recognition of HLA-A3 and HLA-A11 by KIR3DL2 is peptide-specific., Eur J Immunol 2004 Jun; 34(6): 1673-9.

Braud VM, Aldemir H, Breart B, Ferlin WG, Expression of CD94-NKG2A inhibitory receptor is restricted to a subset of CD8+ T cells., Trends Immunol 2003 Apr; 24(4): 162-4.

Bland FA, Lemberg MK, McMichael AJ, Martoglio B, Braud VM, Requirement of the proteasome for the trimming of signal peptide-derived epitopes presented by the nonclassical major histocompatibility complex class I molecule HLA-E., J Biol Chem 2003 Sep; 278(36): 33747-52.

Evans EJ, Hene L, Sparks LM, Dong T, Retiere C, Fennelly JA, Manso-Sancho R, Powell J, Braud VM, Rowland-Jones SL, McMichael AJ, Davis SJ, The T cell surface–how well do we know it?, Immunity 2003 Aug; 19(2): 213-23.

Shiroishi M, Tsumoto K, Amano K, Shirakihara Y, Colonna M, Braud VM, Allan DS, Makadzange A, Rowland-Jones S, Willcox B, Jones EY, van der Merwe PA, Kumagai I, Maenaka K, Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G., Proc Natl Acad Sci U S A 2003 Jul; 100(15): 8856-61.

Saito M, Braud VM, Goon P, Hanon E, Taylor GP, Saito A, Eiraku N, Tanaka Y, Usuku K, Weber JN, Osame M, Bangham CR, Low frequency of CD94/NKG2A+ T lymphocytes in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis, but not in asymptomatic carriers., Blood 2003 Jul; 102(2): 577-84.

Anjuère F, George-Chandy A, Audant F, Rousseau D, Holmgren J, Czerkinsky C, Transcutaneous immunization with cholera toxin B subunit adjuvant suppresses IgE antibody responses via selective induction of Th1 immune responses., J Immunol 2003 Feb; 170(3): 1586-92.

Heinzel AS, Grotzke JE, Lines RA, Lewinsohn DA, McNabb AL, Streblow DN, Braud VM, Grieser HJ, Belisle JT, Lewinsohn DM, HLA-E-dependent presentation of Mtb-derived antigen to human CD8+ T cells., J Exp Med 2002 Dec; 196(11): 1473-81.

Allan DS, Lepin EJ, Braud VM, O'Callaghan CA, McMichael AJ, Tetrameric complexes of HLA-E, HLA-F, and HLA-G., J Immunol Methods 2002 Oct; 268(1): 43-50.

Martín P, Del Hoyo GM, Anjuère F, Arias CF, Vargas HH, Fernández-L A, Parrillas V, Ardavín C, Characterization of a new subpopulation of mouse CD8alpha+ B220+ dendritic cells endowed with type 1 interferon production capacity and tolerogenic potential., Blood 2002 Jul; 100(2): 383-90.

Wang EC, McSharry B, Retiere C, Tomasec P, Williams S, Borysiewicz LK, Braud VM, Wilkinson GW, UL40-mediated NK evasion during productive infection with human cytomegalovirus., Proc Natl Acad Sci U S A 2002 May; 99(11): 7570-5.

García P, Llano M, de Heredia AB, Willberg CB, Caparrós E, Aparicio P, Braud VM, López-Botet M, Human T cell receptor-mediated recognition of HLA-E., Eur J Immunol 2002 Apr; 32(4): 936-44.

Martín P, Ruiz SR, del Hoyo GM, Anjuère F, Vargas HH, López-Bravo M, Ardavín C, Dramatic increase in lymph node dendritic cell number during infection by the mouse mammary tumor virus occurs by a CD62L-dependent blood-borne DC recruitment., Blood 2002 Feb; 99(4): 1282-8.

Braud VM, Tomasec P, Wilkinson GW, Viral evasion of natural killer cells during human cytomegalovirus infection., Curr Top Microbiol Immunol 2002 ; 269(): 117-29.

Lemberg MK, Bland FA, Weihofen A, Braud VM, Martoglio B, Intramembrane proteolysis of signal peptides: an essential step in the generation of HLA-E epitopes., J Immunol 2001 Dec; 167(11): 6441-6.

Ardavín C, Martínez del Hoyo G, Martín P, Anjuère F, Arias CF, Marín AR, Ruiz S, Parrillas V, Hernández H, Origin and differentiation of dendritic cells., Trends Immunol 2001 Dec; 22(12): 691-700.

Anjuère F, Ardavín C, Isolation of mouse thymic dendritic cells., Methods Mol Med 2001 ; 64(): 23-8.

Lepin EJ, Bastin JM, Allan DS, Roncador G, Braud VM, Mason DY, van der Merwe PA, McMichael AJ, Bell JI, Powis SH, O'Callaghan CA, Functional characterization of HLA-F and binding of HLA-F tetramers to ILT2 and ILT4 receptors., Eur J Immunol 2000 Dec; 30(12): 3552-61.

Martín P, del Hoyo GM, Anjuère F, Ruiz SR, Arias CF, Marín AR, Ardavín C, Concept of lymphoid versus myeloid dendritic cell lineages revisited: both CD8alpha(-) and CD8alpha(+) dendritic cells are generated from CD4(low) lymphoid-committed precursors., Blood 2000 Oct; 96(7): 2511-9.

Anjuère F, del Hoyo GM, Martín P, Ardavín C, Langerhans cells develop from a lymphoid-committed precursor., Blood 2000 Sep; 96(5): 1633-7.

King A, Allan DS, Bowen M, Powis SJ, Joseph S, Verma S, Hiby SE, McMichael AJ, Loke YW, Braud VM, HLA-E is expressed on trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells., Eur J Immunol 2000 Jun; 30(6): 1623-31.

Allan DS, McMichael AJ, Braud VM, The ILT family of leukocyte receptors., Immunobiology 2000 May; 202(1): 34-41.

Tomasec P, Braud VM, Rickards C, Powell MB, McSharry BP, Gadola S, Cerundolo V, Borysiewicz LK, McMichael AJ, Wilkinson GW, Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40., Science 2000 Feb; 287(5455): 1031.

Anjuère F, Martínez del Hoyo G, Martín P, Ardavín C, Langerhans cells acquire a CD8+ dendritic cell phenotype on maturation by CD40 ligation., J Leukoc Biol 2000 Feb; 67(2): 206-9.

Allan DS, Colonna M, Lanier LL, Churakova TD, Abrams JS, Ellis SA, McMichael AJ, Braud VM, Tetrameric complexes of human histocompatibility leukocyte antigen (HLA)-G bind to peripheral blood myelomonocytic cells., J Exp Med 1999 Apr; 189(7): 1149-56.

Braud VM, Allan DS, McMichael AJ, Functions of nonclassical MHC and non-MHC-encoded class I molecules., Curr Opin Immunol 1999 Feb; 11(1): 100-8.

Anjuère F, Martín P, Ferrero I, Fraga ML, del Hoyo GM, Wright N, Ardavín C, Definition of dendritic cell subpopulations present in the spleen, Peyer’s patches, lymph nodes, and skin of the mouse., Blood 1999 Jan; 93(2): 590-8.

Braud VM, McMichael AJ, Regulation of NK cell functions through interaction of the CD94/NKG2 receptors with the nonclassical class I molecule HLA-E., Curr Top Microbiol Immunol 1999 ; 244(): 85-95.

O'Callaghan CA, Tormo J, Willcox BE, Braud VM, Jakobsen BK, Stuart DI, McMichael AJ, Bell JI, Jones EY, Structural features impose tight peptide binding specificity in the nonclassical MHC molecule HLA-E., Mol Cell 1998 Mar; 1(4): 531-41.

Braud VM, Allan DS, O'Callaghan CA, Söderström K, D'Andrea A, Ogg GS, Lazetic S, Young NT, Bell JI, Phillips JH, Lanier LL, McMichael AJ, HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C., Nature 1998 Feb; 391(6669): 795-9.

Braud VM, McMichael AJ, Cerundolo V, Differential processing of influenza nucleoprotein in human and mouse cells., Eur J Immunol 1998 Feb; 28(2): 625-35.

Braud VM, Allan DS, Wilson D, McMichael AJ, TAP- and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide., Curr Biol 1998 Jan; 8(1): 1-10.

Anjuère F, Kuznetsov D, Romero P, Cerottini JC, Jongeneel CV, Luescher IF, Differential roles of T cell receptor alpha and beta chains in ligand binding among H-2Kd-restricted cytolytic T lymphocyte clones specific for a photoreactive Plasmodium berghei circumsporozoite peptide derivative., J Biol Chem 1997 Mar; 272(13): 8505-14.

Anjuère F, Horvath C, Cerottini JC, Luescher IF, Induction of CTL in vivo by major histocompatibility complex class I-peptide complexes covalently associated on the cell surface., Eur J Immunol 1995 Jun; 25(6): 1535-40.